Comprehensive Genomic and Immune Profiling of Early-Onset Colorectal Cancer

This study investigated 1757 colorectal cancer (CRC) specimens that received comprehensive genomic and immune profiling, and identified that Early-onset CRC (patient age ≤ 50y) had lower tumor mutational burden (TMB) and reduced immunogenicity compared to late-onset CRC (patient age > 50y).